Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02233452Phase 4Completed
Phase 4, randomised, double-blind trial in neuropathic pain comparing Methadone, Ketamine and Methadone + Ketamine (3 arms). Primary endpoint: Pain intensity assessed by Visual Analogical Scale at 90 days. Started Jan 2012; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02233452.